Table 1 Sociodemographic and medical characteristics in the mothers of children with HCV infection.
Non-treatment group (n = 11) | Treatment group (n = 25) | p value | |
|---|---|---|---|
Age at this study, y, mean ± SD | 40.5 ± 4.6 | 49.5 ± 5.5 | p < 0.001 |
Final academic background (%) | n.s. | ||
Junior high school | 1 (8.3) | 2 (8.0) | |
High school | 3 (27.3) | 10 (40.0) | |
Career college | 1 (8.3) | 3 (12.0) | |
University | 5 (41.7) | 10 (40.0) | |
Others | 1 (8.3) | 0 (0.0) | |
Number of deliverly, mean ± SD | 1.9 ± 0.5 | 2.4 ± 0.8 | n.s. |
Cirrhosis in relatives (%) | 2 (18.1) | 2 (8.0) | n.s. |
HCC in relatives (%) | 1 (8.3) | 1 (4.0) | n.s. |
Mother’s HCV infection (%) | 11 (100) | 25 (100) | n.s. |
Age at infection detected, y, mean ± SD | 26.8 ± 4.9 | 27.4 ± 5.5 | n.s. |
Experience of HCV treatment (%) | 10 (90.9) | 20 (80.0) | n.s. |
Therapeutic agents (%) | n.s. | ||
IFN | 1 (10.0) | 2 (10.0) | |
Peg-IFN + RBV | 3 (30.0) | 11 (55.0) | |
DAA | 7 (70.0) | 14 (70.0) | |
Moderate or severe adverse events (%) | 2 (20.0) | 9 (45.0) | n.s. |
Viral clearance (%) | 9 (90.0) | 20 (100) | n.s. |
